Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection.
Journal: Molecular cancer therapeutics
Published: May 04, 2016
Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab.
Journal: Molecular cancer therapeutics
Published: December 07, 2015
Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 06, 2015
TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy.
Journal: Molecular cancer therapeutics
Published: September 10, 2015
Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.
Journal: Molecular cancer therapeutics
Published: May 04, 2015
Lower island trapezius myocutaneous flap reconstruction of a large neck defect in an infant.
Journal: International journal of pediatric otorhinolaryngology
Published: May 24, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026